LIDDS (Local Implant Drug Delivery System) is a Swedish life sciences company developing innovative pharmaceutical products based on its proprietary drug delivery technology. LIDDS was initially founded by researchers and entrepreneurs at Uppsala University, departments of pharmacy and material sciences and University of Gothenburg, departments of urology and oncology, and within the network of P.U.L.S. AB (www.pulsinvest.se), LIDDS is located in Helsingborg, Sweden, in one of Europe’s premiere biotechnology regions.